Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
COVID-19 pandemic is a serious concern in the new era. Acute respiratory distress
syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even …
syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even …
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
VP Chavda, R Bezbaruah, S Dolia, N Shah… - Process …, 2023 - Elsevier
The pandemic COVID-19 has spread widely throughout the globe and has been responsible
for millions of deaths worldwide. Recently, it has been identified that there is no specific and …
for millions of deaths worldwide. Recently, it has been identified that there is no specific and …
The role of antigen-presenting cells in the pathogenesis of COVID-19
Abstract Coronavirus Disease 2019 (COVID-19) is one of the three lethal coronavirus
outbreaks in the recent two decades and a serious threat to global health all over the world …
outbreaks in the recent two decades and a serious threat to global health all over the world …
[HTML][HTML] Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
Antivirals already on the market and expertise gained from the SARS and MERS outbreaks
are gaining momentum as the most effective way to combat the coronavirus outbreak. SARS …
are gaining momentum as the most effective way to combat the coronavirus outbreak. SARS …
Obesity or increased body mass index and the risk of severe outcomes in patients with COVID-19: a protocol for systematic review and meta-analysis
Y Yang, L Wang, J Liu, S Fu, L Zhou, Y Wang - Medicine, 2022 - journals.lww.com
Background: To assess the effect of obesity or a high body mass index (BMI) on the risk of
severe outcomes in patients with coronavirus disease 2019 (COVID-19). Methods: Studies …
severe outcomes in patients with coronavirus disease 2019 (COVID-19). Methods: Studies …
[HTML][HTML] Correlation between COVID-19 and hepatitis B: A systematic review
YF He, ZG Jiang, N Wu, N Bian… - World journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND There is growing evidence that patients with coronavirus disease 2019
(COVID-19) frequently present with liver impairment. Hepatitis B virus (HBV) remains a …
(COVID-19) frequently present with liver impairment. Hepatitis B virus (HBV) remains a …
Antiinflammatory activities of Curcumin and Spirulina: focus on their role against COVID-19
A Perna, E Hay, C Sellitto, E Del Genio… - Journal of Dietary …, 2023 - Taylor & Francis
Nutraceuticals have for several years aroused the interest of researchers for their countless
properties, including the management of viral infections. In the context of the COVID-19 …
properties, including the management of viral infections. In the context of the COVID-19 …
[图书][B] Role of Essential Oils in the Management of COVID-19
Coronavirus disease 2019 (COVID-19) has emerged as a global health threat.
Unfortunately, there are very limited approved therapeutics available with established …
Unfortunately, there are very limited approved therapeutics available with established …
Corticosteroids in critical COVID-19: Are all corticosteroids equal?
Background. The hyperinflammation seen as part of a dysregulated immune response to
SARS-CoV-2 in its most severe form leads to acute respiratory distress syndrome (ARDS) …
SARS-CoV-2 in its most severe form leads to acute respiratory distress syndrome (ARDS) …
Caution with the use of dexamethasone in patients with COVID-19 in its initial phases
JLC Rubio, IA Millan, M Moreno-Higueras… - Revista Clínica …, 2021 - Elsevier
Introduction The effect of dexamethasone in the initial phase of infection by SARS-CoV-2
and its influence on COVID-19 is not well defined. We describe clinical-radiological …
and its influence on COVID-19 is not well defined. We describe clinical-radiological …